US Patent Family Members and Approved Drugs for Slovenia Patent: 3019516
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: SI3019516
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 10,274,466 | 2035-07-11 | bevacizumab | Genentech, Inc. | AVASTIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
